ポイントオブケア感染症検査の世界市場レポート 2025年

ポイントオブケア感染症検査の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR13.7％で80億2,000万米ドルに成長します。予測期間中に予想される成長の原動力は、迅速診断に対する需要の増加、感染症の流行の高まり、遠隔地や資源に乏しい地域での採用拡大、分散型ヘルスケアへのシフト、政府の支援策や資金援助などです。予測期間における主な動向としては、分子診断学の発展、高度なポイントオブケア検査機器の開発、バイオセンサーと検出技術の革新、モバイルヘルスアプリケーションの進歩、ヘルスケアプロバイダーとテクノロジー企業間の協力的パートナーシップなどが挙げられます。

伝染病の流行の増加は、今後のポイントオブケア感染症検査市場の成長を促進すると予想されます。伝染病とは、直接接触、空気中の飛沫、またはその他の感染方法によって人から人へと広がる可能性のある病気のことです。このような疾病の発生が増加しているのは、地域や国を越えて移動する人が増え、感染因子の拡散が加速していることが主な原因です。ポイントオブケア感染症検査は、伝染病の発見と診断を迅速化し、タイムリーな治療を可能にするとともに、地域社会内での感染リスクを低減するのに役立ちます。例えば、2024年6月、英国健康安全保障局は、2022年第40週から2023年第15週までに、イングランドの108のNHSトラストが、インフルエンザの確認による1,681件の重症患者入院を記録したと報告しました。これに対し、前シーズンのインフルエンザによる入院は114のトラストで182件にすぎず、2022年第39週までに316件に増加しました。このように、伝染性疾患の増加がポイントオブケア感染症検査市場の成長に拍車をかけています。

ポイントオブケア感染症検査市場の各社は、検査精度の向上、結果までの時間の短縮、患者の転帰の改善を目的として、独自のマイクロ流体技術などの革新的技術の統合をますます進めています。マイクロ流体技術には、少量の流体をマイクロスケールで操作する特殊なシステムが含まれ、迅速かつ正確でコスト効率の高い分析が可能です。この技術は、サンプルの収集、分析、結果出力を統合した迅速な現場での病原体検出を可能にすることで、POC（ポイント・オブ・ケア）感染症検査にメリットをもたらし、集中的な検査室での検査を必要とすることなく、診断のスピードとアクセシビリティを向上させます。例えば、日本に本社を置く診断薬会社であるシスメックス株式会社は、2023年6月、抗菌薬感受性を直接検出する初のポイント・オブ・ケアソリューションであるPA-100 ASTシステムを欧州で発売しました。このシステムは、高度なマイクロ流体技術により、細菌感染症の迅速な同定と抗菌薬効果の評価を可能にし、従来の方法に比べて処理時間を大幅に短縮します。コンパクトなデスクトップ・サイズの分析装置と使い捨てのサンプル・カートリッジが含まれており、プライマリ・ケア診療所のような患者に近い環境での使用に最適です。本システムは、より迅速で正確な抗菌薬療法の決定を促進するよう設計されており、診断効率を向上させることで、抗菌薬耐性との世界の闘いに貢献します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のポイントオブケア感染症検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のポイントオブケア感染症検査市場：成長率分析
• 世界のポイントオブケア感染症検査市場の実績：規模と成長, 2019-2024
• 世界のポイントオブケア感染症検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界のポイントオブケア感染症検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のポイントオブケア感染症検査市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• キットと試薬
• 機器
• 世界のポイントオブケア感染症検査市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ラテラルフロー免疫測定
• 凝集試験
• フロースルー試験または免疫濃縮アッセイ
• 分子診断
• その他の技術
• 世界のポイントオブケア感染症検査市場：疾患別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヒト免疫不全ウイルスのポイントオブケア検査
• クロストリジウム・ディフィシルのPOC検査
• B型肝炎ウイルスのポイントオブケア検査
• 肺炎または連鎖球菌関連感染症
• RSウイルスのPOC検査
• ヒトパピローマウイルスのPOC検査
• インフルエンザまたはインフルエンザのポイントオブケア検査
• その他の疾患
• 世界のポイントオブケア感染症検査市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断センター
• 研究・学術機関
• 在宅ケア環境
• その他のエンドユーザー
• 世界のポイントオブケア感染症検査市場、キットと試薬、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 検査キット
• 試薬
• 世界のポイントオブケア感染症検査市場、機器、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ポータブルデバイス
• 自動分析装置

第7章 地域別・国別分析

• 世界のポイントオブケア感染症検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のポイントオブケア感染症検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ポイントオブケア感染症検査市場：競合情勢
• ポイントオブケア感染症検査市場：企業プロファイル
  • Cardinal Health Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Becton Dickinson and Company
• Quest Diagnostics Incorporated
• bioMerieux Societe Anonyme
• QuidelOrtho Corporation
• Bio-Rad Laboratories Inc.
• DiaSorin Societa per Azioni
• Danaher Corporation
• Cue Health Inc.
• Nova Biomedical Corporation
• Seegene Incorporated
• Biosynex Societe Anonyme
• Trivitron Healthcare Private Limited
• EKF Diagnostics Holdings plc
• Trinity Biotech Public Limited Company
• bioLytical Laboratories Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ポイントオブケア感染症検査市場2029：新たな機会を提供する国
• ポイントオブケア感染症検査市場2029：新たな機会を提供するセグメント
• ポイントオブケア感染症検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Point of care (POC) infectious disease testing involves diagnostic tests conducted at or near the location of patient care, such as in hospitals, clinics, doctor's offices, or even at home. These tests are designed to quickly and accurately detect infectious diseases, providing immediate results to support timely treatment decisions. POC tests are typically easy to use, require minimal equipment, and deliver results within minutes to hours, making them particularly useful when fast diagnosis is essential.

The primary product categories in point of care infectious disease testing are kits and reagents, as well as instruments. Kits and reagents consist of pre-prepared components used in point-of-care diagnostics to rapidly identify infectious agents through reactions with patient samples. Common technologies include lateral flow immunoassay, agglutination tests, flow-through tests, immunoconcentration assays, and molecular diagnostics, among others. The diseases tested for include human immunodeficiency virus (HIV), Clostridium difficile, hepatitis B virus, pneumonia or streptococcus-related infections, respiratory syncytial virus, human papillomavirus, influenza, and more. Point-of-care testing is utilized by various end-users, including hospitals, diagnostic centers, research and academic institutions, homecare settings, and others.

The point of care infectious disease testing market research report is one of a series of new reports from The Business Research Company that provides point of care infectious disease testing market statistics, including the point of care infectious disease testing industry global market size, regional shares, competitors with the point of care infectious disease testing market share, detailed point of care infectious disease testing market segments, market trends, and opportunities, and any further data you may need to thrive in the point of care infectious disease testing industry. This point of care infectious disease testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The point of care infectious disease testing market size has grown rapidly in recent years. It will grow from $4.21 billion in 2024 to $4.79 billion in 2025 at a compound annual growth rate (CAGR) of 14.0%. The growth observed in the past can be attributed to the rising demand for rapid diagnostic solutions, the increasing incidence of infectious diseases, greater healthcare awareness, higher healthcare expenditure, and the growing adoption of home care and self-testing solutions.

The point of care infectious disease testing market size is expected to see rapid growth in the next few years. It will grow to $8.02 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth expected in the forecast period is driven by the increasing demand for rapid diagnostics, the rising prevalence of infectious diseases, greater adoption in remote and resource-constrained areas, a shift toward decentralized healthcare, and supportive government initiatives and funding. Key trends in the forecast period include advancements in molecular diagnostics, development of advanced point-of-care testing devices, innovations in biosensors and detection technologies, progress in mobile health applications, and collaborative partnerships between healthcare providers and technology companies.

The increasing prevalence of contagious diseases is expected to drive the growth of the point-of-care infectious disease testing market in the future. A contagious disease is one that can spread from person to person through direct contact, airborne droplets, or other transmission methods. The growing incidence of such diseases is largely due to increased human mobility, as more people move across regions and countries, which accelerates the spread of infectious agents. Point-of-care infectious disease testing helps speed up the detection and diagnosis of contagious diseases, allowing for timely treatment and reducing the risk of transmission within communities. For example, in June 2024, the UK Health Security Agency reported that from week 40 of 2022 to week 15 of 2023, 108 NHS trusts in England recorded 1,681 critical care admissions due to confirmed influenza. In comparison, the previous flu season saw only 182 admissions across 114 trusts, which increased to 316 by week 39 of 2022. Thus, the rising number of contagious diseases is fueling the growth of the point-of-care infectious disease testing market.

Companies in the point-of-care infectious disease testing market are increasingly integrating innovative technologies such as proprietary microfluidic technology to improve test accuracy, reduce time-to-results, and enhance patient outcomes. Microfluidic technology involves specialized systems that manipulate small fluid volumes at the microscale, enabling fast, precise, and cost-effective analysis. This technology benefits point-of-care infectious disease testing by allowing rapid, on-site pathogen detection with integrated sample collection, analysis, and result output, thus enhancing diagnostic speed and accessibility without requiring centralized laboratory testing. For instance, in June 2023, Sysmex Corporation, a diagnostics company based in Japan, launched the PA-100 AST System in Europe, the first point-of-care solution for directly detecting antimicrobial susceptibility. Using advanced microfluidic technology, this system enables quick identification of bacterial infections and assessment of antimicrobial effectiveness, significantly reducing processing times compared to conventional methods. It includes a compact, desktop-sized analyzer and single-use sample cartridges, making it ideal for near-patient settings such as primary care clinics. Designed to facilitate faster and more accurate antimicrobial therapy decisions, this system contributes to the global fight against antimicrobial resistance by improving diagnostic efficiency.

In July 2024, F. Hoffmann-La Roche AG, a Swiss pharmaceutical company, acquired LumiraDx's point-of-care technology for $295 million. This acquisition allows Roche to expand access to decentralized diagnostic testing by incorporating LumiraDx's versatile point-of-care platform into its diagnostics portfolio. This integration aims to provide timely and actionable results across primary care and underserved healthcare settings. LumiraDx, a U.S.-based medical equipment manufacturer, specializes in point-of-care infectious disease testing.

Major players in the point of care infectious disease testing market are Cardinal Health, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, bioMerieux Societe Anonyme, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., DiaSorin Societa per Azioni, Danaher Corporation, Cue Health Inc., Nova Biomedical Corporation, Seegene Incorporated, Biosynex Societe Anonyme, Trivitron Healthcare Private Limited, EKF Diagnostics Holdings plc, Trinity Biotech Public Limited Company, and bioLytical Laboratories Inc.

North America was the largest region in the point of care infectious disease testing market in 2024. Asia-Pacific is expected to be the Fastest-Growing region in the forecast period. The regions covered in point-of-care infectious disease testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the point-of-care infectious disease testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care infectious disease testing market consists of revenues earned by entities by providing services such as rapid diagnostic testing, disease screening, and onsite sample analysis for infectious conditions. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care infectious disease testing market also includes sales of handheld analyzers, lateral flow assays, molecular testing devices, and related consumables used for the immediate detection of infectious diseases. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point Of Care Infectious Disease Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point of care infectious disease testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point of care infectious disease testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The point of care infectious disease testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Kits And Reagents; Instruments
• 2) By Technology: Lateral Flow Immunoassay; Agglutination Test; Flow-through Test Or Immunoconcentration Assay; Molecular Diagnostics; Other Technologies
• 3) By Disease: Human Immunodeficiency Virus Point-of-Care Testing; Clostridium Difficile Point-of-Care Testing; Hepatitis B Virus Point-of-Care Testing; Pneumonia or Streptococcus Associated Infections; Respiratory Syncytial Virus Point-of-Care Testing; Human Papillomavirus Point-of-Care Testing; Influenza Or Flu Point-of-Care Testing; Other Diseases
• 4) By End Use: Hospitals; Diagnostic Centers; Research and Academic Institutes; Homecare Settings; Other End Users
• Subsegments:
• 1) By Kits And Reagents: Test Kits; Reagents
• 2) By Instruments: Portable Devices; Automated Analyzers
• Companies Mentioned: Cardinal Health; F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point Of Care Infectious Disease Testing Market Characteristics

3. Point Of Care Infectious Disease Testing Market Trends And Strategies

4. Point Of Care Infectious Disease Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Point Of Care Infectious Disease Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Point Of Care Infectious Disease Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Point Of Care Infectious Disease Testing Market Growth Rate Analysis
• 5.4. Global Point Of Care Infectious Disease Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Point Of Care Infectious Disease Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Point Of Care Infectious Disease Testing Total Addressable Market (TAM)

6. Point Of Care Infectious Disease Testing Market Segmentation

• 6.1. Global Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kits And Reagents
• Instruments
• 6.2. Global Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lateral Flow Immunoassay
• Agglutination Test
• Flow-Through Test Or Immunoconcentration Assay
• Molecular Diagnostics
• Other Technologies
• 6.3. Global Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Human Immunodeficiency Virus Point-Of-Care Testing
• Clostridium Difficile Point-Of-Care Testing
• Hepatitis B Virus Point-Of-Care Testing
• Pneumonia Or Streptococcus Associated Infections
• Respiratory Syncytial Virus Point-Of-Care Testing
• Human Papillomavirus Point-Of-Care Testing
• Influenza Or Flu Point-Of-Care Testing
• Other Diseases
• 6.4. Global Point Of Care Infectious Disease Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Centers
• Research And Academic Institutes
• Homecare Settings
• Other End Users
• 6.5. Global Point Of Care Infectious Disease Testing Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Test Kits
• Reagents
• 6.6. Global Point Of Care Infectious Disease Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Portable Devices
• Automated Analyzers

7. Point Of Care Infectious Disease Testing Market Regional And Country Analysis

• 7.1. Global Point Of Care Infectious Disease Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Point Of Care Infectious Disease Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Point Of Care Infectious Disease Testing Market

• 8.1. Asia-Pacific Point Of Care Infectious Disease Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Point Of Care Infectious Disease Testing Market

• 9.1. China Point Of Care Infectious Disease Testing Market Overview
• 9.2. China Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Point Of Care Infectious Disease Testing Market

• 10.1. India Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Point Of Care Infectious Disease Testing Market

• 11.1. Japan Point Of Care Infectious Disease Testing Market Overview
• 11.2. Japan Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Point Of Care Infectious Disease Testing Market

• 12.1. Australia Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Point Of Care Infectious Disease Testing Market

• 13.1. Indonesia Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Point Of Care Infectious Disease Testing Market

• 14.1. South Korea Point Of Care Infectious Disease Testing Market Overview
• 14.2. South Korea Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Point Of Care Infectious Disease Testing Market

• 15.1. Western Europe Point Of Care Infectious Disease Testing Market Overview
• 15.2. Western Europe Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Point Of Care Infectious Disease Testing Market

• 16.1. UK Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Point Of Care Infectious Disease Testing Market

• 17.1. Germany Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Point Of Care Infectious Disease Testing Market

• 18.1. France Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Point Of Care Infectious Disease Testing Market

• 19.1. Italy Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Point Of Care Infectious Disease Testing Market

• 20.1. Spain Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Point Of Care Infectious Disease Testing Market

• 21.1. Eastern Europe Point Of Care Infectious Disease Testing Market Overview
• 21.2. Eastern Europe Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Point Of Care Infectious Disease Testing Market

• 22.1. Russia Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Point Of Care Infectious Disease Testing Market

• 23.1. North America Point Of Care Infectious Disease Testing Market Overview
• 23.2. North America Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Point Of Care Infectious Disease Testing Market

• 24.1. USA Point Of Care Infectious Disease Testing Market Overview
• 24.2. USA Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Point Of Care Infectious Disease Testing Market

• 25.1. Canada Point Of Care Infectious Disease Testing Market Overview
• 25.2. Canada Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Point Of Care Infectious Disease Testing Market

• 26.1. South America Point Of Care Infectious Disease Testing Market Overview
• 26.2. South America Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Point Of Care Infectious Disease Testing Market

• 27.1. Brazil Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Point Of Care Infectious Disease Testing Market

• 28.1. Middle East Point Of Care Infectious Disease Testing Market Overview
• 28.2. Middle East Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Point Of Care Infectious Disease Testing Market

• 29.1. Africa Point Of Care Infectious Disease Testing Market Overview
• 29.2. Africa Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Point Of Care Infectious Disease Testing Market Competitive Landscape And Company Profiles

• 30.1. Point Of Care Infectious Disease Testing Market Competitive Landscape
• 30.2. Point Of Care Infectious Disease Testing Market Company Profiles
  • 30.2.1. Cardinal Health Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Point Of Care Infectious Disease Testing Market Other Major And Innovative Companies

• 31.1. Becton Dickinson and Company
• 31.2. Quest Diagnostics Incorporated
• 31.3. bioMerieux Societe Anonyme
• 31.4. QuidelOrtho Corporation
• 31.5. Bio-Rad Laboratories Inc.
• 31.6. DiaSorin Societa per Azioni
• 31.7. Danaher Corporation
• 31.8. Cue Health Inc.
• 31.9. Nova Biomedical Corporation
• 31.10. Seegene Incorporated
• 31.11. Biosynex Societe Anonyme
• 31.12. Trivitron Healthcare Private Limited
• 31.13. EKF Diagnostics Holdings plc
• 31.14. Trinity Biotech Public Limited Company
• 31.15. bioLytical Laboratories Inc.

32. Global Point Of Care Infectious Disease Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point Of Care Infectious Disease Testing Market

34. Recent Developments In The Point Of Care Infectious Disease Testing Market

35. Point Of Care Infectious Disease Testing Market High Potential Countries, Segments and Strategies

• 35.1 Point Of Care Infectious Disease Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Point Of Care Infectious Disease Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Point Of Care Infectious Disease Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer